https://www.selleckchem.com/pr....oducts/anlotinib-al3
Use of drug combinations is recommended by hypertension guidelines for most patients because of the greater blood pressure (BP)-lowering effect compared with monotherapy. However, no evidence is available on outcome benefits of treatment strategies based on drug combinations vs. simpler treatment regimens, using data from randomized clinical trials (RCTs). We evaluated drug combination therapies of different complexity. Electronic databases were searched for BP-lowering RCTs that compared combination treatment or monotherapy vs
Like
Comment
Share
